首页 | 本学科首页   官方微博 | 高级检索  
     

重组人骨形成蛋白4基因腺相关病毒载体的构建
引用本文:董智勇,郑召民,邝冠明,李佛保. 重组人骨形成蛋白4基因腺相关病毒载体的构建[J]. 中国修复重建外科杂志, 2007, 21(7): 738-742
作者姓名:董智勇  郑召民  邝冠明  李佛保
作者单位:1. 青岛市胶州中心医院骨科
2. 中山大学附属第一医院脊柱外科,广州,510080
基金项目:教育部霍英东教育基金优选资助课题;广东省自然科学基金
摘    要:目的 构建重组人骨形成蛋白4(human bone morphogenetie protein4,hBMP-4)基因腺相关病毒载体。方法 根据hBMP4的基因序列设计引物,上游引入EcoRⅠ位点,下游引入Sal Ⅰ位点,以EX-A0242M01hBMP4为模板扩增目的基因。将hBMP-4基因克隆入pUC18载体中,获得重组质粒pUCl8hBMP-4。然后用EcoRⅠ与Sal Ⅰ酶切pUC18-hBMP-4及质粒pSNAV,回收酶切片段,T4DNA连接酶16C过夜,转化大肠杆菌DH5a感受肽细胞,筛选阳性克隆获得pSNAV-hBMP-4,EcoRⅠ/SalⅡ双酶切鉴定,并行全基因测序。转染BHK21细胞,G418筛选培养,获得抗药克隆细胞株。HsV1-rc/△UL2感染,包装此细胞株并收获病毒载体AAV-hBMP-4。行DNA点杂交法测定病毒滴度,SDS-PAGE分析判断病毒纯度。结果 PCR电泳及酶切鉴定表明,pSNAV-hBMP-4重组成功,基因测序显示装入pSNAV质粒中的hBMP-4基因正确;AAV-hBMP-4病毒的大致滴度为1.5×10^12μg/ml,分泌蛋白浓度为0.124mg/ml,病毒载体纯度在95%以上。结论 实验获得的病毒载体滴度高、感染性好,可以满足骨组织工程的需要。

关 键 词:骨组织工程  重组人骨形成蛋白  腺相关病毒
修稿时间:2006-05-112007-04-16

CONSTRUCTION OF RECOMBINANT ADENO-ASSOCIATED VIRUS VECTOR WITH HUMAN BONE MORPHOGENETIC PROTEIN 4 GENE
DONG Zhiyong, ZHENG Zhaomin, KUANG Guanming,et al.. CONSTRUCTION OF RECOMBINANT ADENO-ASSOCIATED VIRUS VECTOR WITH HUMAN BONE MORPHOGENETIC PROTEIN 4 GENE[J]. Chinese journal of reparative and reconstructive surgery, 2007, 21(7): 738-742
Authors:DONG Zhiyong   ZHENG Zhaomin   KUANG Guanming  et al.
Affiliation:Department of Orthopaedics, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou Guangdong, 510080, P. R. China.
Abstract:OBJECTIVE: To construct the recombinant adeno-associated virus vector with human bone morphogenetic protein 4 gene (AAV-hBMP-4). METHODS: The hBMP-4 gene primer was designed basing on the corresponding gene sequence in GenBank. EcoR I site was introduced into the upstream of the primer and Sal I site into downstream. The hBMP-4 gene was amplified with the template of EX-A0242-M01-hBMP-4, then was cloned into pUC18 vector to construct recombinant plasmid pUC18-hBMP-4. The plasmids pUC18-hBMP-4 and plasmid pSNAV cut by EcoR I and Sal I enzyme, the fragments were collected and linked with T4 DNA ligase at 16 C over night, recombinant plasmid pSNAV-hBMP-4 was obtained. The recombinant plasmid was then transfected into BHK21 cells using Lipofectamine TM2000. The G418 resistant cells were obtained consequently. These cells were infected with HSV1-rc/deltaUL2 which has the function of packaging and copying the recombinant AAV. After purification, the construction of recombinant AAV-hBMP-4 was completed. RESULTS: The construction of the recombinant pSNAV-hBMP-4 was confirmed by PCR electrophoresis and digestion with restriction enzyme. The gene sequence in the recombinant pSNAV-hBMP-4 was correct. The virus titer was about 1.5 x 10(12) microg/ml. The purity of the virus was more than 95% using the SDS-PAGE method. CONCLUSION: With this method, high virus titers and purity of AAV-hBMP-4 can be acquired successfully and it is useful to bone tissue engineering.
Keywords:Bone tissue engineering   Recombinant human bone morphogenetic protein   Adeno associated virus
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号